The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $88.21

Today's change-8.79 -9.06%
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $88.21

Today's change-8.79 -9.06%
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.

Gilead Sciences Inc crosses below 125-day moving average

Gilead Sciences Inc closed sharply lower Friday, dropping (U.S.)$8.79 or 9.06% to (U.S.)$88.21 and crossing below its 125-day moving average. Over the last five days, shares have lost 13.46% and are down 12.83% for the last year to date. This security has underperformed the S&P 500 by 11.82% during the last year.

Key company metrics

  • Open(U.S.) $91.19
  • Previous close(U.S.) $97.00
  • High(U.S.) $92.53
  • Low(U.S.) $87.80
  • Bid / Ask(U.S.) $88.25 / (U.S.) $88.38
  • YTD % change-12.83%
  • Volume33,629,186
  • Average volume (10-day)11,865,862
  • Average volume (1-month)11,231,022
  • Average volume (3-month)12,130,474
  • 52-week range(U.S.) $81.89 to (U.S.) $123.37
  • Beta1.08
  • Trailing P/E7.55×
  • P/E 1 year forward7.19×
  • Forward PEG5.74×
  • Indicated annual dividend(U.S.) $1.88
  • Dividend yield2.13%
  • Trailing EPS(U.S.) $11.69
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.47%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue7,7948,5068,2958,244
Total other revenue--------
Total revenue7,7948,5068,2958,244
Gross profit6,6017,4447,2317,246
Total cost of revenue1,1931,0621,064998
Total operating expense3,1432,8852,7102,628
Selling / general / administrative6851,066903812
Research & development1,265757743818
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income4,6515,6215,5855,616
Interest income (expense), net non-operating-230-230-165-140
Gain (loss) on sale of assets--------
Other--------
Income before tax4,5025,4375,4725,511
Income after tax3,5674,6854,5924,497
Income tax, total9357528801,014
Net income3,5664,6834,6004,492
Total adjustments to net income--------
Net income before extra. items3,5664,6834,6004,492
Minority interest-1-28-5
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,5664,6834,6004,492
Inc. avail. to common incl. extra. items3,5664,6834,6004,492
Diluted net income3,5664,6834,6004,492
Dilution adjustment00----
Diluted weighted average shares1,4121,4701,5031,540
Diluted EPS excluding extraordinary itemsvalue per share2.533.193.062.92
Dividends per sharevalue per share--0.430.430.43
Diluted normalized EPSvalue per share2.533.193.062.92